Affiliation:
1. Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University
2. Philips healthcare (China)
Abstract
Abstract
Objective: Whether there are alterations in the glymphatic system (GS) of patients with non-alcoholic fatty liver disease (NAFLD) remains unclear. This study aims to investigate alterations in GS function in patients with NAFLD and explore the relationship of these alterations with cognition and clinical indicators.
Materials and Methods: Forty-three patients with pre-cirrhotic NAFLD (male: 37, mean age: 38.2 ± 6.7 years) and twenty-three age-, sex-, and education-matched controls (male: 17, mean age: 41.0 ± 6.7 years) underwent diffusion tensor imaging (DTI) examination and cognitive measurements. The DTI analysis along the perivascular space (DTI-ALPS) index, calculated from the DTI data, assessed differences in GS function between the two groups. Linear regression analysis examined the relationship between the ALPS index and Z-transformed cognitive scores. Spearman/Pearson correlation analysis was conducted for assessing the relationship of the ALPS index with clinical indicators.
Results: After adjusted for age, sex, and BMI, NAFLD patients exhibited significantly lower ALPS index and higher diffusivity of projection fibers in the direction of the y-axis than controls (both P < 0.001). In the NAFLD group, the ALPS index was significantly correlated with the Mini-Mental State Examination score (beta [95% CI] = 2.123 [0.156, 4.091], P= 0.035) and the clock drawing score (beta [95% CI] = 4.233 [0.073, 8.393], P= 0.046) after adjusting for age, sex, body mass index, and education level. In addition, there was a significantly positive correlation between the ALPS index and visceral adipose tissue (r = 0.353, P= 0.020) after adjusting for age, sex, and BMI in NAFLD patients.
Conclusion: Patients with NAFLD may exhibit glymphatic dysfunction prior to developing cirrhosis. Changes in the GS is associated with cognitive performance in NAFLD. These findings may contribute to understanding the mechanisms underlying cognitive impairment in NAFLD patients.
Publisher
Research Square Platform LLC
Reference43 articles.
1. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives;Kjærgaard KA-O;J Clin Med,2021
2. Weinstein G, Zelber-Sagi S, Preis SR, Beiser AS, DeCarli C, Speliotes EK et al. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study. JAMA Neurol 2018.1.
3. Seo SW, Gottesman RF, Clark JM, Hernaez R, Chang Y, Kim C et al. Nonalcoholic fatty liver disease is associated with cognitive function in adults.
4. Systemic symptoms in non-alcoholic fatty liver disease;Julia LN;Dig Dis (Basel Switzerland),2010
5. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation;Cheon SY;Cell Biosci,2022